Elongation Factor ELL (Eleven-Nineteen Lysine-rich Leukemia) Acts as a Transcription Factor for Direct Thrombospondin-1 Regulation
Authors:
- Xi FengXFXi Feng
- Bin BanBBBin Ban
- Jingxia LiuJLJingxia Liu
- Zhou WangZWZhou Wang
- Wuhan XiaoWXWuhan Xiao
Open Access
- 1 July 2009
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (28) , 19142-19152
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasiaOncogene, 2007
- FB1, an E2A fusion partner in childhood leukemia, interacts with U19/EAF2 and inhibits its transcriptional activityCancer Letters, 2007
- Vertebrate MAX-1 is required for vascular patterning in zebrafishProceedings of the National Academy of Sciences, 2006
- Apoptosis induction and growth suppression by U19/Eaf2 is mediated through its ELL‐binding domainThe Prostate, 2006
- An Mll-Dependent Hox Program Drives Hematopoietic Progenitor ExpansionCurrent Biology, 2004
- Mechanisms of Transformation by MLLCritical Reviews™ in Eukaryotic Gene Expression, 2004
- RETRACTED: Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesisCancer Cell, 2003
- The Elongation Domain of ELL Is Dispensable but Its ELL-Associated Factor 1 Interaction Domain Is Essential for MLL-ELL-Induced LeukemogenesisMolecular and Cellular Biology, 2001
- Nonredundant Roles of the Elongation Factor MEN in Postimplantation DevelopmentBiochemical and Biophysical Research Communications, 2000
- Repression of thrombospondin-1 expression, a natural inhibitor of angiogenesis, in polyoma middle T transformed NIH3T3 cellsCancer Letters, 1996